Insmed reported $52.61M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
DBV Technologies DBVT:US USD 14.47M 896K
Acelrx Pharmaceuticals ACRX:US USD 2M 397K
Alimera Sciences ALIM:US USD 8.71M 1.09M
Cytokinetics CYTK:US USD 25.61M 11.18M
Dynavax Technologies DVAX:US USD 3.21M 161K
Heron Therapeutics HRTX:US USD 3.22M 3.32M
Insmed INSM:US USD 52.61M 41.03M
Mirati Therapeutics MRTX:US USD 38.86M 19.41M
Novartis NVS:US USD 5.15B 453M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Seattle Genetics SGEN:US USD 207.85M 63.35M
Ultragenyx Pharmaceutical RARE:US USD 43.27M 19.74M